Korro Bio shareholders approve 2026 meeting items
Korro Bio, Inc. reported the results of its 2026 annual stockholder meeting held on June 10, 2026.
Rhea-AI Filing Summary
Korro Bio, Inc. reported the results of its 2026 annual stockholder meeting held on June 10, 2026. Stockholders elected Nessan Bermingham and Rachel Meyers as Class I directors for three-year terms ending at the 2029 annual meeting.
Both directors received several million votes in favor, with additional votes withheld and broker non-votes recorded. Stockholders also approved, in a non-binding advisory vote, the compensation of Korro’s named executive officers by a wide margin.
In addition, stockholders ratified the selection of Ernst & Young LLP as Korro’s independent registered public accounting firm for the fiscal year ending December 31, 2026. These items collectively confirm continued support for the company’s board, executive pay program, and auditor.
Positive
- None.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Emerging growth company regulatory
non-binding, advisory vote regulatory
independent registered public accounting firm regulatory
Broker Non-Votes financial
Class I directors financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Korro Bio (KRRO) stockholders decide at the 2026 annual meeting?
Who was elected to Korro Bio (KRRO)’s board at the 2026 annual meeting?
Which audit firm did Korro Bio (KRRO) stockholders ratify for fiscal 2026?
What is a broker non-vote in Korro Bio (KRRO)’s 2026 meeting results?
AI-generated analysis. How Rhea-AI works. Not financial advice.